A settlement has been reached regarding the smoking-cessation drug Chantix. Pfizer has agreed to a $44 million class action settlement due to allegations about the drug.

The settlement may affect people who bought Chantix during a certain period. Those who purchased the drug over a six-year period could be eligible for compensation.

Further details about the settlement and eligibility are available, including information on how to determine if you qualify for a payment from the settlement.